Skip to main content
Clinical Trials/NL-OMON52735
NL-OMON52735
Recruiting
Phase 4

A randomized clinical trial to evaluate the efficacy of polyethylene glycol vs psyllium fiber to prevent rebleeding in patients hospitalized with bleeding diverticular disease. - Prevention of rebleeding in diverticular disease.

Elisabeth-Tweesteden ziekenhuis0 sites260 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Bleeding Diverticular disease
Sponsor
Elisabeth-Tweesteden ziekenhuis
Enrollment
260
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Elisabeth-Tweesteden ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • Patients between the ages of 18 or older.
  • Patients who are hospitalized for bleeding diverticular disease in het ETZ.
  • Patients with diverticular disease based on colonoscopy, sigmoïdscopy or
  • CT\-scan \<5 years

Exclusion Criteria

  • Other bleeding diseases of the colon requiring medicinal treatment such as IBD
  • or infection
  • Surgical treatment following initial episode of bleeding diverticular disease.
  • Patients using polyethylene glycol or psyllium fiber regularly, more than twice
  • Patients who are pregnant, lactating or planning pregnancy while enrolled in
  • Patients who are unsuitable for inclusion in the study in the opinion of the
  • investigator for any reason that may compromise the subject\*s safety or
  • confound data interpretation

Outcomes

Primary Outcomes

Not specified

Similar Trials